ML

Maria Carmen Valcarce Lopez

VT Vtv Therapeutics: 15 patents #5 of 50Top 10%
NA Novo Nordisk A/S: 1 patents #951 of 1,775Top 55%
📍 Oak Ridge, NC: #20 of 96 inventorsTop 25%
🗺 North Carolina: #3,009 of 45,564 inventorsTop 7%
Overall (All Time): #288,782 of 4,157,543Top 7%
16
Patents All Time

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDate
11974989 Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs Jennifer Freeman 2024-05-07
11833136 Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs Jennifer Freeman 2023-12-05
11096946 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Eliot Ohlstein 2021-08-24
10980861 Glucokinase activator compositions for the treatment of diabetes Tung Fong 2021-04-20
10952993 Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs Jennifer Freeman 2021-03-23
10588943 Glucokinase activator compositions for the treatment of diabetes Tung Fong 2020-03-17
10456406 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Eliot Ohlstein 2019-10-29
10363244 Compositions comprising metformin and a glucokinase activator Adnan M. M. Mjalli 2019-07-30
10064846 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Adnan M. M. Mjalli 2018-09-04
10004782 Glucokinase activator compositions for the treatment of diabetes Tung Fong 2018-06-26
9968613 Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Eliot Ohlstein 2018-05-15
9855251 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Adnan M. M. Mjalli 2018-01-02
9717710 Treatment of mild and moderate Alzheimer's disease Cesare Orlandi, David Clark, Imogene M. Dunn, Matthew J. Kostura 2017-08-01
9487493 Use of a PPAR-delta agonist for treating muscle atrophy Eliot Ohlstein 2016-11-08
9359313 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Adnan M. M. Mjalli 2016-06-07
RE45183 Heteroaryl-ureas and their use as glucokinase activators Anthony Murray, Jesper Lau, Lone Jeppesen, Per Vedsoe, Michael Ankersen +8 more 2014-10-07